Stock PD2 PATTERSON COMPANIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Patterson Companies, Inc. Deutsche Boerse AG

Equities

PD2

US7033951036

Real-time Estimate Tradegate
Other stock markets
 12:08:57 02/07/2024 BST 		5-day change 1st Jan Change
22.3 EUR -0.45% Intraday chart for Patterson Companies, Inc. -1.75% -8.26%
06-20 Morgan Stanley Adjusts Price Target on Patterson Companies to $28 From $30, Maintains Equalweight Rating MT
06-20 JPMorgan Adjusts Price Target on Patterson Companies to $29 From $30, Maintains Neutral Rating MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The stock, which is currently worth 2025 to 0.38 times its sales, is clearly overvalued in comparison with peers.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company sustains low margins.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
PATTERSON COMPANIES, INC. Stock Patterson Companies, Inc.
-8.26% 2.11B -
ABBOTT LABORATORIES Stock Abbott Laboratories
-6.24% 180B
C+
MEDTRONIC PLC Stock Medtronic plc
-6.39% 98.89B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.97% 66.26B
A
DEXCOM, INC. Stock DexCom, Inc.
-9.61% 44.61B
B-
CENCORA, INC. Stock Cencora, Inc.
+8.84% 44.02B
B-
HOYA CORPORATION Stock Hoya Corporation
+10.13% 40.12B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+12.69% 29.19B
B
TERUMO CORPORATION Stock Terumo Corporation
+13.33% 23.41B
A-
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-7.83% 23.64B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. PDCO Stock
  4. PD2 Stock
  5. Ratings Patterson Companies, Inc.